Top Markets
Coin of the day
DermTech, Inc. DermTech, Inc.

DermTech, Inc.

DMTK
Classement en actions #37065
DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla,... DermTech, Inc., a molecular diagnostics firm headquartered in La Jolla, California, specializes in creating and bringing to market advanced, non-invasive genomic tests. Operating within the United States, their innovative solutions facilitate the diagnosis of various dermatological issues, including skin cancer, inflammatory conditions, and age-related skin concerns. A cornerstone of their offerings is the DermTech Melanoma Test (DMT), a sophisticated gene expression analysis. This assay plays a crucial role in enhancing the early identification of genomic abnormalities, effectively aiding in the exclusion of melanoma and often removing the need for invasive surgical biopsies of suspicious pigmented lesions. The company further provides specialized adhesive kits for convenient skin sample collection. Additionally, they offer gene expression assays designed to analyze key inflammatory pathways such, as Th1, Th2, IFN-gamma, and Th17. Looking ahead, DermTech is actively developing a pipeline of new products, which includes DNA risk assessment tools for UV damage, diagnostic tests for non-melanoma skin cancers, and rule-out tests for cutaneous T-cell lymphoma. They also extend their services by delivering health-related information and support through digital and telecommunication platforms. DermTech's diagnostic products and services are primarily targeted towards medical professionals in the fields of pathology and oncology.
Prix de l'action
$0.069
Dernière synchronisation: 2024-07-22
Capitalisation boursière
$2.06M
Changement (1 jour)
-1.43%
Changement (1 an)
0.00%
Pays
US
Échange DermTech, Inc. (DMTK)

Catégorie

EPS pour DermTech, Inc. (DMTK)
EPS au March 2024 TTM : $-2.70
Selon les derniers rapports financiers et le cours de l'action de DermTech, Inc., l’EPS actuel de la société (TTM) est de $-2.70. À la fin de 2022, la société avait un EPS de $-3.88 une augmentation par rapport à celui de 2021, qui était de $-2.71.
Historique de l'EPS de DermTech, Inc. de 2012 à 2026
EPS à la fin de chaque année
Année EPS Changez
2026 (TTM) $-2.70 -12.62%
2023 $-3.09 -20.36%
2022 $-3.88 43.17%
2021 $-2.71 32.20%
2020 $-2.05 -34.50%
2019 $-3.13 -969.44%
2018 $0.36 0.00%
2017 0.00 -100.00%
2013 $-1.10 69.23%
2012 $-0.65 0.00%
EPS pour des entreprises ou concurrents similaires
Entreprise EPS Différence d’EPS Pays
$18.62 -789.63%
US
$5.65 -309.26%
US
- -
CN
$-1.36 -49.63%
US
$14.24 -627.41%
US